Alvircept sudotox, Recombinant CD4, sCD4-PE40

Specification

• Cat#: THP-0289
• Product Name: Alvircept sudotox, Recombinant CD4, sCD4-PE40
• Cas No: 137487-62-8
• Description: Alvircept sudotox is a form of recombinant CD4 derived from Pneumonas aeruginosa exotoxin A, or 'PE40, which has a size of 59,187 daltons and is an anti-viral agent.
• Sequences: MKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAHMAEEGGSLAALTAHQACHLPLETFTRHRQPRGWEQLEQCGYPVQRLVALYLAARLSWNQVDQVIRNALASPGSGGDLGEAIREQPEQARLALTLAAAESERFVRQGTGNDEAGAANADVVSLTCPVAAGECAGPADSGDALLERNYPTGAEFLGDGGDVSFSTRGTQNWTVERLLQAHRQLEERGYVFVGYHGTFLEAAQSIVFGGVRARSQDLDAIWRGFYIAGDPALAYGYAQDQEPDARGRIRNGALLRVYVPRSSLPGFYRTSLTLAAPEAAGEVERLIGHPLPLRLDAITGPEEEGGRLETILGWPLAERTVVIPSAIPTDPRNVGGDLDPSSIPDKEQAISALPDYASQPGKPPREDLK
• Molecular Weight: 59.187 kDa
• Purity: >99% by SDS-Page and HPLC analysis
• Endotoxin: <0.001 EU per 1 μg of the peptide by the LAL method
• Storage: Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 2-8 °C for 1 week. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
• Application: Alvircept Sudotox has been used in trials studying the treatment of HIV Infections.

Pharmaceutical Information

• Pharmaceutical Application: Alvircept Sudotox